Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.r. Palella FJ, K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, G.A. Satten, et al.
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.
N Engl J Med, 338 (1998), pp. 853-860
[2.]
A. Mocroft, C. Katlama, A.M. Johnson, C. Pradier, F. Antunes, F. Mulcahy, et al.
AIDS across Europe, 1994-1998: the EuroSIDA study.
Lancet, 356 (2000), pp. 291-296
[3.]
M.S. Sulkowski, D.L. Thomas.
Hepatitis C in the HIV-infected person.
Ann Intern Med, 138 (2003), pp. 197-207
[4.]
I. Bica, B. McGovern, R. Dhar, D. Stone, K. Mc Gowan, R. Scheib, et al.
Increasing mortality due to end stage liver disease in patients with human immunodeficiency virus infection.
Clin Infect Dis, 32 (2001), pp. 492-497
[5.]
J. Torre-Cisneros, J.M. Miró.
Trasplante hepático en pacientes infectados por el virus de la inmunodeficiencia humana: el difícil reto de una nueva etapa.
Med Clin (Barc), 113 (1999), pp. 215-219
[6.]
M. Prieto, G. Clemente, F. Casafont, N. Cuende, V. Cuervas-Mons, J. Figueras, et al.
Documento de consenso de indicaciones de trasplante hepático.
Gastroenterol Hepatol, 26 (2003), pp. 355-375
[7.]
M.E. Roland, P.G. Stock.
Review of solid organ transplantation in HIV-infected patients.
Transplantation, 75 (2003), pp. 425-429
[8.]
J. Ockenga, H.L. Tillmann, C. Trautwein, M. Stoll, M.P. Manns, R.E. Scmidt, et al.
Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value.
J Hepatol, 27 (1997), pp. 18-24
[9.]
V. Soriano, J. García-Samaniego, R. Rodríguez-Rosado, J. González, J. Pedreira.
Hepatitis C and HIV infection: biological, clinical and therapeutic implications.
J Hepatol, 31 (1999), pp. 119-123
[10.]
V. Soriano, J. García-Samaniego, E. Valencia, R. Rodríguez-Rosado, F. Muñoz, J. González-Lahoz.
Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.
Eur J Epidemiol, 15 (1999), pp. 1-4
[11.]
A. Sánchez-Quijano, M. Leal, E. Lissen.
Hepatitis crónica por virus C en pacientes coinfectados por el virus de la inmunodeficiencia humana.
Gastroenterol Hepatol, 25 (2002), pp. 423-431
[12.]
C.S. Graham, L.R. Badem, E. Yu, J.M. Mrus, J. Carnie, T. Heeren, et al.
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.
Clin Infect Dis, 33 (2001), pp. 562-569
[13.]
R. Bruno, P. Sacchi, M. Puoti, V. Soriano, G. Filice.
HCV chronic hepatitis in patients with HIV: clinical management issues.
Am J Gastroent, 97 (2002), pp. 1598-1606
[14.]
J.F. Colin, D. Cazals-Hatem, M.A. Loriot, M. Martinot-Peignoux, B.N. Pham, A. Auperin, et al.
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.
Hepatology, 29 (1999), pp. 1306-1310
[15.]
M. Bonacini, S. Govindarajan, A.G. Redeker.
Human immunodeficiency virus infection does not alter serum transaminases and hepatitis virus (HBV) DNA in homosexual patients with chronic HBV infection.
Am J Gastroenterol, 86 (1991), pp. 570-573
[16.]
U. Spengler, M. Lichterfeld, J.K. Rockstroh.
Antiretroviral drug toxicity A challenge for the hepatologist?.
J Hepatol, 36 (2002), pp. 283-294
[17.]
A.O. Ogedegbe, M.S. Sulkowski.
Antiretroviral-associated liver injury.
Clin Liver Dis, 7 (2003), pp. 475-499
[18.]
M. Puoti, F. Gargiulo, E.Q. Roldan, A. Chiodera, L. Palvarini, A. Spinetti, et al.
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment.
J Infect Dis, 181 (2000), pp. 2033-2036
[19.]
A.G. Tzakis, M.H. Cooper, J.S. Dummer, M. Ragni, J.W. Ward, T.E. Starzl.
Transplantation in HIV positive patients.
Transplantation, 49 (1990), pp. 354-358
[20.]
J.S. Dummer, S. Erb, M.K. Breinig, M. Ho, C.R. Rinaldo, P. Gupta, et al.
Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1.043 recipients, 1981-1986.
Transplantation, 47 (1989), pp. 134-140
[21.]
M.V. Ragni, S.F. Dodson, S.C. Hunt, F.A. Bontempo, J.J. Fung.
Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.
Blood, 93 (1999), pp. 1113-1114
[22.]
P.J. Gow, D. Mutimer.
Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy.
AIDS, 15 (2001), pp. 291-292
[23.]
A. Prachalias, P. Anton, C. Taylor, P. Srinivasan, P. Muiesan, J. Wendon, et al.
Liver transplantation in adults coinfected with HIV.
Transplantation, 72 (2001), pp. 1684-1688
[24.]
G.W. Neff, A. Bonham, A.G. Tzakis, M. Ragni, D. Jayaweera, E.R. Schiff, et al.
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
Liver Transpl, 9 (2003), pp. 239-247
[25.]
D. Samuel, J.C. Duclos Vallee, E. Teicher, D. Vittecoq.
Liver transplantation in patients with HIV infection.
J Hepatol, 39 (2003), pp. 3-6
[26.]
P.C. Kuo, P.G. Stock.
Transplantation in the HIV positive patient.
Am J Transpl, 1 (2001), pp. 13-17
[27.]
S.D. Halpern, P.A. Ubel, A.L. Caplan.
Solid-organ transplantation in HIV-infected patients.
N Eng J Med, 347 (2002), pp. 284-287
[28.]
A.M. Sheikh, D.C. Wolf, E. Lebovics, R. Goldberg, H.W. Horowitz.
Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism ad increases blood levels.
Transplantation, 68 (1999), pp. 307-309
[29.]
D. Margolis, A. Heredia, J. Gaywee, D. Oldach, G. Drusano, R. Redfield.
Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity.
J Acquir Immune Defic Syndr, 21 (1999), pp. 362-370
[30.]
A. Schwartz, G. Offermann, F. Keller, I. Benhold, J. L'Age-Stehr, P.H. Krause, et al.
The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation: data on four cases and review of the literature.
Transplantation, 55 (1993), pp. 95-103
[31.]
A. Karpas, M. Lowdell, S.K. Jacobson, F. Hill.
Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK506.
Prc Nat Acad Sci USA, 89 (1992), pp. 8351-8355
[32.]
J. Astermak, T. Lofqvist, S. Schulman, L. Stigendal, S. Lethagen, I.M. Nilsson, et al.
Major surgery seems not to influence HIV disease progression in haemophilia patients.
Br J Haematol, 103 (1998), pp. 10-14
[33.]
Y. Benhamou, T. Poynard.
Treatment of chronic hepatitis B virus infection in patients coinfected with human immunodeficiency virus.
J Hepatol, 39 (2003), pp. S194-S199
[34.]
B. Roche, D. Samuel.
Liver transplantation for hepatitis B virusrelated liver disease: indications, prevention of recurrence and results.
J Hepatol, 39 (2003), pp. S181-S189
[35.]
M. Berenguer, T.L. Wright.
Treatment of recurrence of hepatitis B in transplant patients.
J Hepatol, 39 (2003), pp. S190-S203
[36.]
M. Berenguer.
Natural history of recurrent hepatitis C.
Liver Transpl, 8 (2002), pp. S14-S18
[37.]
M.E. De Vera, B. Eghtesad, J. Ashokkumar, J.J. Fung.
Progression and treatment of recurrent hepatitis C after liver transplantation in patients coinfected wit HIV.
Hepatology, 38 (2003), pp. 161A
[38.]
P.R. John, P.J. Thuluvath.
Outcome of liver transplantation in patients with diabetes mellitus: a case-control study.
Hepatology, 34 (2001), pp. 889-895
[39.]
S. Nair, J. Eustace, P.J. Thuluvath.
Effect of race on outcome of orthotopic liver transplantation: a cohort study.
Lancet, 359 (2002), pp. 287-293
[40.]
L.M. Forman, J.D. Lewis, J.A. Berlin, H.I. Feldman, M.R. Lucey.
The association between hepatitis C infection and survival after orthotopic liver transplantation.
Gastroenterology, 122 (2002), pp. 889-896
[41.]
P.A. Ubel, C. Jepson, J. Baron, T. Mohr, S. McMorrow, D.A. Asch.
The allocation of transplantable organs: do people want to punish patients for causing their illness?.
Liver Transpl, 7 (2001), pp. 600-607
[42.]
D. Goldberg, J. Johnston, S. Cameron, C. Fletcher, M. Stewart, J. McMenamin, et al.
Risk of HIV transmission from patients to surgeons in the era of post-exposure prophylaxis.
J Hosp Infect, 44 (2000), pp. 99-105
[43.]
D.K. Henderson.
Post-exposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.
JAMA, 281 (1999), pp. 931-936
[44.]
J.L. Gerberding.
Occupational exposure to HIV in health care settings.
N Engl J Med, 348 (2003), pp. 826-833
[45.]
M. Johri, P.A. Ubel.
Setting organ allocation priorities: should we care what the public cares about?.
Liver Transplant, 9 (2003), pp. 870-880
[46.]
M.E. Roland, D.V. Havlir.
Responding to organ failure in HIV-infected patients.
N Engl J Med, 348 (2003), pp. 2279-2281
[47.]
M.E. Roland, B. Lo, J. Braff, P.G. Stock.
Key clinical, ethical and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients.
Arch Intern Med, 163 (2003), pp. 1773-1778
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
